Along with NAFLD development, apoptosis of hepatocytes results in the formation of many different substrates, including keratins (K-19) and cytokeratins 18 (CK-18), which can be detected in the blood of patients and are therefore proposed as potential biomarkers of NAFLD progression [4,92]. This evidence concerns the gene KRT19 and metabolic dysfunction-associated steatotic liver disease.